Haleon Pakistan Limited Updated 08 May, 2026 08:31am Haleon Pakistan limited (formerly known as GlaxoSmithKline) was incorporated in Pakistan as a public limited company...
Panadol liquid production: Haleon to pump in £3.58m for modernisation, expansion Published 28 Jan, 2026 07:17am KARACHI: Haleon Pakistan Limited has approved a £3.58 million, approximately Rs1.25 billion, capital investment to...
Haleon Pakistan to invest nearly $5mn in Panadol Liquid packaging expansion Updated 27 Jan, 2026 02:42pm Company says investment aimed at enhancing capacity
Haleon Pakistan Limited: performance and outlook Updated 05 Jan, 2026 07:06am Haleon Pakistan limited (formerly known as GlaxoSmithKline) was incorporated in Pakistan as a public limited company...
Haleon Pakistan Limited Updated 15 Aug, 2025 08:30am Haleon Pakistan limited (formerly known as GlaxoSmithKline) was incorporated in Pakistan as a public limited company...
Production capacity boost: Haleon plans to ramp up investment in Pakistan Published 24 Jul, 2025 06:19am KARACHI: Haleon has planned to ramp up its investment in Pakistan with an initial outlay of $12 million, aimed at...
Haleon establishing ‘Pain Management Institute’ in Lahore Published 21 Jan, 2025 06:12am LAHORE: Haleon, multinational company is establishing a Pain Management Institute in Lahore to carry out research to...
Haleon Pakistan plans to manufacture Centrum multivitamins Updated 12 Dec, 2024 11:01pm KARACHI: Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales...
LHC’s decision to help boost Pakistan’s pharma sector: brokerage house Updated 04 Apr, 2024 07:40pm The Lahore High Court’s (LHC) decision to nullify the stayorder against the deregulation of Maximum Retail Prices...
Haleon rejects Zantac indemnification requests from GSK, Pfizer Published 20 Sep, 2022 12:03pm LONDON: Haleon on Tuesday said it had notified GSK and Pfizer that it had rejected their requests for...
New consumer healthcare giant Haleon worth £31 bn Published 18 Jul, 2022 07:08pm LONDON: Haleon, the consumer healthcare unit spun off by British drugs giant GlaxoSmithKline, was worth around £31...
Pfizer to sell stake in GSK’s consumer health business Published 02 Jun, 2022 06:19am LONDON: Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after...